Author: Tam Constantine S
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.6, 2013-09, pp. : 687-699
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Janus kinase 2 inhibitors in myeloproliferative disorders
By Lucia Eugenio Recchia Anna Grazia Gentile Massimo Bossio Sabrina Vigna Ernesto Mazzone Carla Madeo Antonio Morabito Lucio Gigliotti Vincenzo Stefano Laura De Caruso Nadia Servillo Pasquale Franzese Stefania Bisconte Maria Grazia Gentile Carlo Morabito Fortunato
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. :
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. :
Investigational ABC transporter inhibitors
By Falasca Marco Linton Kenneth J.
Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. :